Literature DB >> 2551821

Angiotensin-induced hypertension in the rat. Sympathetic nerve activity and prostaglandins.

F C Luft1, C S Wilcox, T Unger, R Kühn, G Demmert, P Rohmeiss, D Ganten, R B Sterzel.   

Abstract

To elucidate mechanisms of angiotensin II (Ang II)-related hypertension, we infused angiotensin (76 ng/min s.c.) into rats with minipumps for 10-14 days. Control rats received sham pumps. We measured blood pressure by tail-cuff, and the excretion of aldosterone and prostaglandins (PG) (PGE2, prostacyclin derivative 6kPGF1 alpha, and thromboxane [Tx] derivative TxB2). Angiotensin II increased blood pressure by 20 mm Hg by day 2 and by 90 mm Hg by day 10. Aldosterone excretion increased from 10 to 70 ng/day in Ang II rats by day 7. Urine PGE2 did not increase in angiotensin rats; however, both 6kPGF1 alpha and TxB2 excretion increased with angiotensin. Control rats had no changes in any of these parameters. A sympathetic component was tested in a separate group of angiotensin rats that received phenoxybenzamine (300 micrograms/kg/day) during angiotensin infusion; their increase in blood pressure of 40 mm Hg at 10 days was less than in those rats with angiotensin alone but more than in control rats. Phenoxybenzamine did not influence the angiotensin-induced increases in excretion of 6kPGF1 alpha or TxB2. Additional groups of conscious angiotensin and control rats were equipped with splanchnic nerve electrodes on day 14 for recording of sympathetic nerve activity. Angiotensin rats had greater basal sympathetic nerve activity than the control rats. Incremental methoxamine injections demonstrated altered baroreceptor reflex function in rats receiving angiotensin. We conclude that increased blood pressure with chronic angiotensin infusion is accompanied by increased production of aldosterone and increased sympathetic tone. The latter may be modulated by PG.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551821     DOI: 10.1161/01.hyp.14.4.396

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  16 in total

1.  Time-dependent changes in autonomic control of splanchnic vascular resistance and heart rate in ANG II-salt hypertension.

Authors:  Marcos T Kuroki; Pilar A Guzman; Gregory D Fink; John W Osborn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-23       Impact factor: 4.733

2.  (In)activity-dependent alterations in resting and reflex control of splanchnic sympathetic nerve activity.

Authors:  Nicholas A Mischel; Patrick J Mueller
Journal:  J Appl Physiol (1985)       Date:  2011-10-06

3.  Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans.

Authors:  Hiroyuki Kobori; Qi Fu; Steven D Crowley; Romer A Gonzalez-Villalobos; Ruy R Campos
Journal:  J Appl Physiol (1985)       Date:  2010-12

Review 4.  Renal sympathetic nerve activity in the development of hypertension.

Authors:  Simon C Malpas; Rohit Ramchandra; Sarah-Jane Guild; Fiona McBryde; Carolyn J Barrett
Journal:  Curr Hypertens Rep       Date:  2006-06       Impact factor: 5.369

5.  Cyclooxygenase-1 inhibition attenuates angiotensin II-salt hypertension and neurogenic pressor activity in the rat.

Authors:  Ninitha Asirvatham-Jeyaraj; Andrew J King; Carrie A Northcott; Shivanshu Madan; Gregory D Fink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-06       Impact factor: 4.733

6.  Na+/Ca2+ exchanger overexpression in smooth muscle augments cytosolic Ca2+ in femoral arteries of living mice.

Authors:  Jin Zhang; Youhua Wang; Ling Chen; W Gil Wier; Mordecai P Blaustein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-11-21       Impact factor: 4.733

Review 7.  Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation.

Authors:  John W Osborn; Gregory D Fink; Marcos T Kuroki
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

8.  A role for the thromboxane receptor in L-NAME hypertension.

Authors:  Helene Francois; Natalia Makhanova; Philip Ruiz; Jonathan Ellison; Lan Mao; Howard A Rockman; Thomas M Coffman
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-06

Review 9.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

10.  Arthur C. Corcoran Memorial Lecture. Sympathetic activity, vascular capacitance, and long-term regulation of arterial pressure.

Authors:  Gregory D Fink
Journal:  Hypertension       Date:  2008-12-29       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.